Clinical significance of serum level of transforming growth factor-beta 1 in patients with chronic idiopathic thrombocytopenic purpura
10.3760/cma.j.issn.1008-6315.2009.10.019
- VernacularTitle:慢性特发性血小板减少性紫癜患者血清转化生长因子β1测定的意义
- Author:
Zhenghua ZHANG
;
Zhiguo LONG
;
Zhirong LI
;
Chucheng WAN
;
Hua JIANG
;
Yunjin XIA
- Publication Type:Journal Article
- Keywords:
Chronic idiopathic thrombocytopenic purpura;
Transforming growth factor-beta 1;
ELISA
- From:Clinical Medicine of China
2009;25(10):1059-1060
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical significance of transforming growth factor-beta 1 ( TGF-β1 ) in patients with chronic idiopathic thrombocytopenic purpura(CITP). Methods The serum level of TGF-β1 in 38 pa-tients with initial CITP were detected using enzyme-linked immunosorbent assay(ELISA). Results The serum level of TGF-β1 in initial patients with CITP was significantly higher than that of the controls [( 132.57±5.17) μg/L vs ( 76.81±4.42) μ/L] ( P <0.01 ). The serum level of TGF-β1 in those having good response after therapy was sig-nificantly lower than before treatment[(81.26±3.78)μg/L] (P <0.01 ). There was no difference in TGF-β1 be-tween nonremission [(123.49 ± 4.31 ) μg/L] and initial patients (P > 0.05 ). There was negative correlation between TGF-β1 and platelet count(r = -0. 342 ,P < 0.05 ) ,there was positive correlation between TGF-β1 and megakaryo-cyte count (r = 0.409, P < 0.01 ). Conclusions TGF-β1 partakes in the pathogenesis of CITP, the determination of which in patients with CITP is useful to judge the state of illness, which can be regarded as an assistant index of cur-ative effect.
